At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 5:17:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 1 | 5 | 5 |
| Avg. Estimate | -0.13 | -0.02 | 0.06 | -0.38 |
| Low Estimate | -0.2 | -0.02 | -0.04 | -0.95 |
| High Estimate | -0.01 | -0.02 | 0.19 | -0.1 |
| Year Ago EPS | 0.01 | 0.17 | -0.01 | 0.06 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 6 | 6 |
| Avg. Estimate | 13.53M | 18.5M | 115.72M | 80.57M |
| Low Estimate | -15.3M | 10M | 84.7M | 31M |
| High Estimate | 33M | 33M | 133.01M | 132M |
| Year Ago Sales | 26.61M | 41.46M | 101.21M | 115.72M |
| Sales Growth (year/est) | -49.14% | -55.38% | 14.33% | -30.38% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.03 | -0.06 | -0.06 | -0.13 |
| EPS Actual | 0.01 | 0.17 | -0.08 | 0.07 |
| Difference | 0.04 | 0.23 | -0.02 | 0.2 |
| Surprise % | 135.09% | 382.06% | -42.17% | 154.98% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.02 | 0.06 | -0.38 |
| 7 Days Ago | -0.12 | -0.12 | 0.07 | -0.47 |
| 30 Days Ago | -0.17 | -0.12 | -0.31 | -0.71 |
| 60 Days Ago | -0.17 | -0.12 | -0.31 | -0.71 |
| 90 Days Ago | -0.17 | -0.05 | -0.31 | -0.71 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | 3 | 1 | 4 | 4 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CTMX | -1,351.50% | -111.76% | 676.80% | -763.42% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 9/13/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 8/22/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 6/27/2024 |
| Upgrade | Piper Sandler: Neutral to Overweight | 5/28/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 5/9/2024 |
Related Tickers
SPRO Spero Therapeutics, Inc.
0.9551
-4.30%
ASMB Assembly Biosciences, Inc.
15.21
-3.80%
NXTC NextCure, Inc.
0.9700
+2.11%
MRSN Mersana Therapeutics, Inc.
1.6000
-8.05%
HLVX HilleVax, Inc.
1.8600
+1.64%
BOLT Bolt Biotherapeutics, Inc.
0.5000
-0.70%
AADI Aadi Bioscience, Inc.
3.3900
+46.12%
AFMD Affimed N.V.
1.1900
+0.85%
IKNA Ikena Oncology, Inc.
1.5500
-3.73%
CLRB Cellectar Biosciences, Inc.
0.2350
-1.26%